Recent studies presented at the European Society of Cardiology conference in London have shown that weight loss medications may revolutionize healthcare.

• A new important discovery for an anti-aging drug 

• “The Anti-Aging Benefits of Collagen for Women’s Skin: How it Helps Resist Wrinkles”

This is not only through combating aging but also by improving overall health and increasing lifespan. These medications, typically used to treat type 2 diabetes, have proven their effectiveness in enhancing quality of life.

Previous research had already shown that type 2 diabetes medications reduce the risk of death among people suffering from obesity or overweight and cardiovascular diseases. However, recent studies have revealed that these medications have effects beyond what was initially expected. The results showed that individuals who took these medications were less likely to die from all causes, not just from cardiac causes.

• Unexpected ways summer can damage your skin

• 7 Habits that slow down aging progress 

According to the British newspaper The Guardian, Professor Harlan Krumholz from Yale University’s School of Medicine stated that some diabetes medications offer health benefits far beyond what was anticipated. He explained that these drugs are not only helpful in preventing heart attacks but also slow down the aging process.

The studies included the “SELECT” trial in the United States, which involved 17,604 people aged 45 or older. The participants were overweight or obese and had cardiovascular diseases, but they were not diabetic. They were given either the actual drug or a placebo and were followed for over three years.

• “It’s not too late” – Global Calls to Alleviate Alzheimer’s

• Reasons Why Elderly People Act Like Children

During the study, around 833 people died, 58% from cardiovascular causes and 42% from other causes, such as infections, which were the most common cause of death in this group. The results showed that those who took the drug were less likely to die from infections compared to those who took the placebo. The drug also reduced the risk of adverse cardiac outcomes.

Benjamin Scirica, a professor at Harvard University and the lead author of one of the studies, said: “The significant reduction in non-cardiovascular deaths, particularly those caused by infections, was surprising.” He added: “These findings confirm that being overweight and obese increases the risk of death from several causes, which can be mitigated with proper treatment.”

• Early Symptoms Indicating Mental Health Issues in the Elderly

• “Smart Insulin”: A Revolutionary New Treatment to Combat Diabetes